NASDAQ: CMMBChemomab Therapeutics Ltd Stock Ownership - Who owns Chemomab Therapeutics?
Insider buying vs selling
Have Chemomab Therapeutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when CMMB insiders and whales buy or sell their stock.
CMMB Shareholders
What type of owners hold Chemomab Therapeutics Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Access Industries Holdings LLC | 1.67% | 6,911,166 | $6.34M | Insider |
| Gabriel Capital Management Ltd | 1.22% | 5,034,150 | $4.62M | Insider |
| Orbimed Israel GP Ltd | 0.54% | 2,241,274 | $2.06M | Insider |
| Morgan Stanley | 0.39% | 1,614,134 | $1.48M | Institution |
| George Adi Mor | 0.32% | 1,339,964 | $1.23M | Insider |
| Orbimed Advisors LLC | 0.23% | 940,990 | $863.83k | Institution |
| Peter Thiel | 0.21% | 877,973 | $805.98k | Insider |
| Sphera Funds Management Ltd | 0.18% | 738,048 | $677.53k | Institution |
| Yelin Lapidot Holdings Management Ltd | 0.14% | 578,291 | $530.87k | Institution |
| Dennison T. Veru | 0.10% | 396,540 | $364.02k | Insider |
CMMB vs Biotech Stocks
Chemomab Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.